Sarteau, Angelica Cristello http://orcid.org/0000-0002-7303-4311
Kahkoska, Anna R.
Crandell, Jamie
Igudesman, Daria http://orcid.org/0000-0001-5209-4625
Corbin, Karen D.
Kichler, Jessica C.
Maahs, David M.
Muntis, Frank
Pratley, Richard
Seid, Michael
Zaharieva, Dessi
Mayer-Davis, Elizabeth
Article History
Received: 15 October 2021
Revised: 8 April 2022
Accepted: 17 May 2022
First Online: 22 June 2022
Competing interests
: A.R.K. received financial support for travel from Novo Nordisk A/S to present work unrelated to this analysis in 2019. For work unrelated to the present analysis, D.M.M. reports research support from the NIH, JDRF, NSF, and the Helmsley Charitable Trust, and his institution has had research support from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Tandem, and Roche. D.M.M. has consulted for Abbott, Aditxt, the Helmsley Charitable Trust, Sanofi, Novo Nordisk, Eli Lilly, Medtronic, Insulet, and Dompe. All other authors have nothing to disclose. For work unrelated to the present analysis, D.Z. reports fellowship funding from ISPAD-JDRF, grants from the Helmsley Charitable Trust, and Medtronic Diabetes, Ascensia Diabetes Care, and Insulet Canada speaker bureau participation. R.P. reports consulting fees from AstraZeneca; consulting fees from Glytec, LLC; grants from Hanmi Pharmaceutical Co.; grants and consulting fees from Janssen; consulting fees from Merck; grants from Metavention; consulting fees from Mundipharma; grants, speaker fees, and consulting fees from Novo Nordisk; consulting fees from Pfizer; grants from Poxel SA; grants and consulting fees from Sanofi; consulting fees from Scohia Pharma Inc.; consulting fees from Sun Pharmaceutical Industries; personal consulting fees from Sanofi US Services, Inc. Except for consulting fees in February 2018 and June 2018 from Sanofi US Services, Inc., R.P. services were paid for directly to AdventHealth, a nonprofit organization. All other authors report no financial ties to products used in the study or perceived/potential conflicts of interest.
: Written informed consent and assent were provided by parent and adolescent, respectively, at the first in-person baseline measurement visit of the Flexible Lifestyles Empowering Change (FLEX) trial.